Anglo-German relations are defined by mutual incomprehension – Technologist

Anglo-German relations are defined by mutual incomprehension – Technologist

“MARK my words. Within a year she’ll be gone. She’s stuffed.” Thus a senior Cameroon surveyed the landscape almost exactly a year—and what feels like many political ages—ago over dinner. He was talking of Angela Merkel, whose handling of the refugee crisis 10 Downing Street considered suicidal. Surely, the thinking went, no leader could accept … Read more

Biden proposes a tax raise on billionaires, corporations, and portrays Trump as the candidate of the rich – Technologist

Biden proposes a tax raise on billionaires, corporations, and portrays Trump as the candidate of the rich – Technologist

President Biden prepares to deliver his State of the Union address to Congress, Washington DC, on March 7, 2024. SHAWN THEW / VIA REUTERS Having failed to sell his economic record to US voters still furious about (past) price hikes, Biden took advantage of the State of the Union address to launch a tax battle. … Read more

Opinion | What’s the point of a mandatory pension that offers no financial security? – Technologist

Opinion | What’s the point of a mandatory pension that offers no financial security? – Technologist

The conviction was deep that savings are more reliably nurtured by savers themselves, rather than entrusted to highly paid fund managers. Families believed fund managers had more interest in the fees that made them rich than in the financial security of Hong Kong families in old age. I confess I also nurtured a prejudice. My … Read more

Zacks Small Cap Research – BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS… – Technologist

Zacks Small Cap Research – BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS… – Technologist

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Phase 3b Trial Design Announced; SPA Submitted to the FDA On March 4, 2024, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) presented a poster at the MDA Clinical and Scientific Conference with an outline of the proposed design for a Phase 3b trial of … Read more

Apple: Reasons For Selloff & How It May Present An Opportunity (Rating Downgrade) (AAPL) – Technologist

Apple: Reasons For Selloff & How It May Present An Opportunity (Rating Downgrade) (AAPL) – Technologist

ozgurdonmaz Apple (NASDAQ:AAPL), now the second-largest company in the world in terms of market cap, is experiencing a rare year of significant underperformance amid a slew of bad news and worries about its future growth prospects. Let’s make sense of all the noise, tackle every reason for the selloff, and assess whether or not it’s … Read more

x